APOE polymorphism status (E4) may help in predicting the risk of recurrent implantation failure.

Parinaz MohtasebiMaryam EslamiFariba RamezanaliParnaz Borjian BoroujeniZeinab Rokhsat TalabMohammad Reza Zamanian

Published in: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2021)

The E4 polymorphism is correlated with RIF occurrence in women undergoing assisted reproductive treatment and potentially can be considered as a risk factor to the human implantation process.

Keyphrases

endothelial cells
risk factors
polycystic ovary syndrome
induced pluripotent stem cells
high fat diet
type diabetes
pluripotent stem cells
pregnant women
mycobacterium tuberculosis
combination therapy